Literature DB >> 6494917

Effect of cell-cell interactions on drug sensitivity and growth of drug-sensitive and -resistant tumor cells in spheroids.

P J Tofilon, N Buckley, D F Deen.   

Abstract

Multicellular spheroids were grown from mixtures of rat brain tumor cells sensitive (9L) and resistant (R3) to 1,3-bis(2-chloroethyl)-1-nitrosourea. Percentages of each cell subpopulation in these spheroids were estimated with the sister chromatid exchange assay and were found to be approximately the same as those used to initiate spheroids. Spheroids grown from 9L cells alone had a higher growth rate than spheroids grown from R3 cells alone. However, the growth rate of mixed-cell spheroids was essentially the same as that of pure 9L spheroids and was independent of the percentages of R3 cells in mixed-cell spheroids. The sensitivity of 9L cells in mixed-cell spheroids treated with 1,3-bis(2-chloroethyl)-1-nitrosourea, estimated by changes in the number of sister chromatid exchanges per metaphase induced by treatment, decreased as the percentage of R3 cells increased. These effects are probably the result of an interaction between the two cell subpopulations held in three-dimensional contact, a situation similar to that in tumors in situ. The results suggest why one cell subpopulation of tumors does not become dominant during growth and indicate that interactions between cell subpopulations can influence the sensitivity of one subpopulation to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6494917     DOI: 10.1126/science.6494917

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics.

Authors:  R Bradford; H Koppel; G J Pilkington; D G Thomas; J L Darling
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

2.  Representativeness of microorgans from human colorectal tumors.

Authors:  S D Finkelstein; R Sayegh; P A Swalsky; A Bakker; R Guzman; B Rotman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting.

Authors:  B Rotman; C Teplitz; K Dickinson; J P Cozzolino
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

5.  Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions.

Authors:  J W Rak; R S Kerbel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

6.  The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.

Authors:  J Fick; F G Barker; P Dazin; E M Westphale; E C Beyer; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  In vitro chemosensitivity test of human brain tumors using a three-dimensional organ culture with a collagen gel matrix.

Authors:  K Yuki; T Uozumi; Y Kodama; K Kurisu; T Mikami
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.

Authors:  R A Vescio; C H Redfern; T J Nelson; S Ugoretz; P H Stern; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Evaluation of the probability of spontaneous transfer of drug resistance between cells in culture.

Authors:  C K Luk; I F Tannock
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

Review 10.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.